Instil Bio has put its 128,097-square-foot Tarzana cell therapy plant back on the block with JLL and set a Nov. 17 call for offers, testing how much investors will pay for a nearly new cGMP facility leased to AstraZeneca through 2039 that its owner built for roughly $172 million.
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
A local developer entity that has spent years converting El Segundo's old...
ByThe RegistryNovember 4, 2026Co/Relate West Adams, a 2023-built co-living community of 30 five-bedroom townhomes on...
ByThe RegistryNovember 4, 2026Plaza Continental Group, which filed for Chapter 11 protection in March, is...
ByThe RegistryNovember 4, 2026A renovated, four-story Class A office building on Aliso Viejo's Summit Office...
ByThe RegistryNovember 4, 2026Error: Contact form not found.